Prof. Hong Yang 杨弘
Chief Physician, Professor
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and comprehensive treatment of small pulmonary nodules, lung cancer, esophageal cancer, and cardia cancer. Expertise in minimally invasive thoracoscopic and robotic surgery, preoperative chemoradiotherapy for advanced esophageal cancer, and systemic lymph node dissection.
Dr. Yang is Deputy Director of the Guangdong Esophageal Cancer Institute and Chief Physician in the Department of Thoracic Surgery at Sun Yat-sen University Cancer Center. Holding a PhD and serving as a doctoral supervisor, Dr. Yang is a Principal Investigator at the State Key Laboratory of Oncology in South China and a Guangdong Outstanding Young Medical Talent.
Professional roles
- Vice Chair, Esophageal Tumor Integrated Rehabilitation Professional Committee, China Anti-Cancer Association
- Member, Esophageal Cancer Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Young Experts Committee, Chinese Society of Clinical Oncology (CSCO)
- Chair, Targeted Therapy Professional Committee, Guangdong Provincial Chest Tumor Prevention and Treatment Research Association
Name order: in Chinese the family name comes first (Yang Hong). Papers usually list the name as Hong Yang or Yang H.
Selected publications
151 papers on PubMed matched by name and affiliation; 19 as first or senior author since 2016. Most recent first- or senior-author papers:
- Clin Transl Med, 2026 (senior author): Sintilimab plus cisplatin and nab-paclitaxel induction treatment for locally advanced borderline-resectable oesophageal squamous cell carcinoma: A single-arm, prospective, phase 2 study (NEOCRTEC2001). PubMed 42112766
- Mol Biomed, 2025 (senior author): Circulating tumor DNA as a marker of molecular residual disease in resected esophageal squamous cell carcinoma. PubMed 40963072
- Int J Surg, 2025 (senior author): Long-term efficacy and progression patterns of paclitaxel plus cisplatin and 5-fluorouracil induction chemotherapy for locally advanced, borderline-resectable esophageal squamous cell carcinoma: results from a phase II NEOCRTEC1601 study. PubMed 40146234
- Lancet Respir Med, 2024 (senior author): Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial. PubMed 39305910
- Ann Surg Oncol, 2024 (senior author): A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial. PubMed 37919448
- EClinicalMedicine, 2023 (senior author): A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901). PubMed 37560259
- Transl Lung Cancer Res, 2023 (senior author): Prognostic value of L4 lymph node dissection during video-assisted thoracoscopic surgery in patients with left-sided non-small cell lung cancer: a single-center, retrospective cohort study. PubMed 37057116
- Cerebrovasc Dis, 2023 (senior author): Total Cerebral Small Vessel Disease Burden Predicts the Outcome of Acute Stroke Patients after Intra-Arterial Thrombectomy. PubMed 36913934
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion